An interventional study of High Intensity Exercise Training and Moderate Intensity Exercise Training in Type 2 Diabetes, sponsored by University of Central Arkansas. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years. Per ClinicalTrials.gov, last updated 2014-02-03.
Sponsored by University of Central Arkansas · Not applicable, Interventional, and Treatment
Among 3,300 studies in Diabetes Mellitus, Type 2 with a site in United States — 340 open to participants now, 475 under way, 47 of them phase 3. Diabetes Mellitus, Type 2 · United States.
Among the 3,300 studies in Diabetes Mellitus, Type 2 with a site in United States, this one is the 2,470th largest by enrollment of the 2,953 interventional ones, is one of 152 that started in 2011, is one of 1,240 with no phase, and was the 1,142nd registered.
10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.
This study's enrollment of 21 is below the median of 80 across 8,350 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →340 of the 3,300 studies in Diabetes Mellitus, Type 2 with a site in United States are open now, in 12 countries. Each count lists the studies.
Of the 883 Diabetes Mellitus, Type 2 studies recruiting now, 373 (42%) set no upper age limit and 384 (43%) stop at 75 or younger; 52 take children under 18; 203 take healthy volunteers.
This study: 18 Years to 69 Years · all sexes · no healthy volunteers.
The full table on the hub →3,300 studies; the count open now beside each. This study's row is marked.
First in 1976; this study’s year is marked. 152 started in 2011.
Median enrollment 90 across the 2,953 interventional studies, 128 across the 336 observational. Of the 2,648 that completed or were terminated, 1,165 (44%) have results posted.
1,482 of 3,300 have an industry lead sponsor. The 10 most frequent:
University of Central Arkansas is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
University of Central Arkansas has 2 studies filed under Diabetes Mellitus, Type 2 — fewer than ten, so there is no comparison to draw.
194 of the studies in Diabetes Mellitus, Type 2 with a site in United States that are under way reach primary completion within a year, 8 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06858878Phase 3AmgenEfficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | 2027-01-21 |
| NCT06731075Phase 3Oramed, Ltd.A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. | 2027-04-25 |
| NCT07220759Phase 3Novo Nordisk A/SWeight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide | 2027-05-12 |
| NCT07817251Phase 3Novo Nordisk A/SResearch Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema | 2027-06-09 |
| NCT06993792Phase 3Eli Lilly and CompanyA Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes | 2027-08 |
Among the 3,300 studies in Diabetes Mellitus, Type 2 with a site in United States, from their registry updates:
The purpose of this randomized clinical trial is to compare the effect of moderate versus high intensity exercise training on physical fitness and physical function in patients with type 2 diabetes. The research hypothesis is that high intensity exercise training will be superior to moderate intensity on such outcomes in individuals with type 2 diabetes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
High intensity resistance and aerobic training
Behavioral: High Intensity Exercise Training
Moderate intensity resistance and aerobic training
Behavioral: Moderate Intensity Exercise Training
* High intensity resistance and aerobic training * Resistance training is performed 2 days per week for 3 months * Aerobic training is performed on the same days as resistance training and 1 additional day per week.
* Moderate intensity resistance and aerobic training * Resistance training is performed on 2 days per week for 3 months. * Aerobic training is performed on the same days as resistance training and 1 additional day per week.
Muscle Strength
Time frame: Baseline and 3 months thereafter
Physical Function
Time frame: Baseline and 3 months thereafter
Exercise Capacity
Time frame: Baseline and 3 months thereafter
The record gives a start of Sep 2011 and a primary completion of Aug 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Central Arkansas